Creating innovative therapies and novel delivery methods

Atossa Genetics is a clinical-stage biopharmaceutical company focusing on breast cancer and other breast conditions.

Transforming the Breast Cancer Paradigm

  • Endoxifen

    We are developing the promise of endoxifen and exploiting its potential to both help prevent as well as to treat breast cancer with our proprietary Topical and Oral Endoxifen.

  • Microcatheters

    We are developing proprietary intraductal microcatheter technology for the potential delivery of drugs and immunotherapies (such as CAR-T) through the breast ducts directly to the site of the cancer.

Advancing
Our Programs

We are advancing programs to help develop treatments that are effective and affordable.

Advancing
Our Programs

We are advancing programs to help develop treatments that are effective and affordable.

Developing Solutions to Address all Sections of the Breast Cancer Paradigm

  • Prevention Window

  • Window-of-Opportunity (Pre-surgery)

  • Refractory (Post-surgery)

  • Gynecomastia

A Global Effort

We work with organizations throughout the world to move our programs forward in an efficient and cost-effective manner.

United States Hawaii Netherlands Sweden Australia Taiwan

A Global Effort

United States Hawaii Netherlands Sweden Australia Taiwan

We work with organizations throughout the world to move our programs forward in an efficient and cost-effective manner.

In the News

Font Resize
Contrast